Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients

BACKGROUND: Despite significant progress with antiprogrammed cell death protein 1 (PD-1) therapy, a substantial fraction of metastatic melanoma patients show upfront therapy resistance. Biomarkers for outcome are missing and the association of baseline immune function and clinical outcome remains to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Gérard, Alexandre, Doyen, Jerome, Cremoni, Marion, Bailly, Laurent, Zorzi, Kevin, Ruetsch-Chelli, Caroline, Brglez, Vesna, Picard-Gauci, Alexandra, Troin, Laura, Esnault, Vincent L.M., Passeron, Thierry, Montaudié, Henri, Seitz-Polski, Barbara
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183201/
https://ncbi.nlm.nih.gov/pubmed/34088741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2021-002512
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados